Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CBLB | Q13191 | 1/20 | 0.33 |
| ▸ | PDCD1 | Q15116 | 3/20 | 0.32 |
| ▸ | CD274 | Q9NZQ7 | 3/20 | 0.32 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.31 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.31 |
| ▸ | MAP3K5 | Q99683 | 1/20 | 0.31 |
| ▸ | RAF1 | P04049 | 1/20 | 0.30 |
| ▸ | VSIR | Q9H7M9 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30153055 | 1.00 | CBLB (0.33) | CBLBPDCD1CD274CYP11B1CYP11B2 | |
| SCHEMBL30152929 | 0.94 | CBLB (0.33) | CBLBMAP3K5VSIR | |
| SCHEMBL24820581 | 0.94 | CBLB (0.33) | CBLBMAP3K5VSIR | |
| SCHEMBL30153071 | 0.91 | CBLB (0.32) | CBLB | |
| SCHEMBL24819866 | 0.91 | CBLB (0.32) | CBLB | |
| SCHEMBL24821930 | 0.91 | CBLB (0.39) | CBLBRAF1 | |
| SCHEMBL24820587 | 0.89 | CBLB (0.38) | CBLBPDCD1CD274RAF1VSIR | |
| SCHEMBL24818776 | 0.88 | S1PR1 (0.33) | CBLBPDCD1CD274MAP3K5 | |
| SCHEMBL24820112 | 0.88 | CBLB (0.33) | CBLBMAP3K5 | |
| SCHEMBL24819058 | 0.88 | CBLB (0.32) | CBLBMAP3K5VSIR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117858865-A | CBL-B modulators and uses thereof | 林伯士克莱奥公司 | 2024-04-09 | — | — | CN | disclosed |
| WO-2022272248-A1 | CBL-B MODULATORS AND USES THEREOF | NIMBUS CLIO, INC. (US) | 2022-12-29 | — | — | WO | disclosed |